Insider · CIK 0001790214

Zuga Matt

Reports to the SEC for 4 companies · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001790214

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-22	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−1,687 sh	$1.86	−$3,137.82	304,924
2026-01-21	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−2,473 sh	$1.81	−$4,469.206	306,611
2026-01-16	ABOSAcumen Pharmaceuticals, Inc.A Award	CFO & Chief Business Officer	AAward	+99.1K sh	—	—	309,084
2026-01-16	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	CFO & Chief Business Officer	AAward	+149K sh	—	—	148,700
2026-01-08	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−6,888 sh	$1.82	−$12.5K	209,951
2026-01-07	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−4,105 sh	$2.00	−$8,189.475	218,539
2026-01-07	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−1,700 sh	$1.99	−$3,376.54	216,839
2026-01-06	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−5,100 sh	$1.97	−$10K	222,644
2026-01-05	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−4,000 sh	$1.96	−$7,842.4	227,744
2025-05-29	ELUTELUTIA INC. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+60.3K sh	—	—	60,339
2025-01-23	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−28.9K sh	$1.72	−$49.6K	231,744
2025-01-21	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−4,364 sh	$1.60	−$6,986.328	260,646
2025-01-06	ABOSAcumen Pharmaceuticals, Inc.A Award	CFO & Chief Business Officer	AAward	+66.8K sh	—	—	265,010
2025-01-06	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	CFO & Chief Business Officer	AAward	+100K sh	—	—	100,300
2025-01-03	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−13.2K sh	$1.84	−$24.4K	198,210
2024-06-06	ELUTELUTIA INC. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+31.8K sh	—	—	31,835
2024-01-18	ABOSAcumen Pharmaceuticals, Inc.S Sale	CFO & Chief Business Officer	SSale	−4,242 sh	$3.71	−$15.7K	211,445
2024-01-02	ABOSAcumen Pharmaceuticals, Inc.A Award	CFO & Chief Business Officer	AAward	+106K sh	—	—	215,687
2024-01-02	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	CFO & Chief Business Officer	AAward	+159K sh	—	—	159,000
2023-01-17	ABOSAcumen Pharmaceuticals, Inc.A Award	CFO & Chief Business Officer	AAward	+33.5K sh	—	—	109,687
2023-01-17	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	CFO & Chief Business Officer	AAward	+151K sh	—	—	150,800
2022-12-29	ABOSAcumen Pharmaceuticals, Inc.M Exercise/Conversion	CFO & Chief Business Officer	MExercise/Conversion	+50K sh	$1.19	+$59.5K	76,187
2022-12-29	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	CFO & Chief Business Officer	MExercise/Conversion	−50K sh	—	—	401,369
2022-01-19	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	CFO & Chief Business Officer	AAward	+150K sh	—	—	150,000
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.C Conversion	CFO & Chief Business Officer	CConversion	+26.2K sh	—	—	26,187
2021-07-06	ABOSAcumen Pharmaceuticals, Inc. · Series A-1 Preferred StockC Conversion	CFO & Chief Business Officer	CConversion	−15.7K sh	—	—	15,659
2021-07-06	ABOSAcumen Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	CFO & Chief Business Officer	CConversion	−10.5K sh	—	—	10,528
2019-11-13	TELATELA Bio, Inc.C Conversion	Director	CConversion	+269 sh	—	—	12,944
2019-11-13	TELATELA Bio, Inc.C Conversion	Director	CConversion	+2,931 sh	—	—	15,875
2019-11-13	TELATELA Bio, Inc.C Conversion	Director	CConversion	+20K sh	—	—	280,790
2019-11-13	TELATELA Bio, Inc.C Conversion	Director	CConversion	+218K sh	—	—	498,606
2019-11-13	TELATELA Bio, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−493K sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−6,643 sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−5.38M sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−72.4K sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Warrant (right to buy)C Conversion	Director	CConversion	−124K sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Warrant (right to buy)C Conversion	Director	CConversion	+124K sh	—	—	123,653
2019-11-13	TELATELA Bio, Inc. · Warrant (right to buy)C Conversion	Director	CConversion	−1,665 sh	—	—	0
2019-11-13	TELATELA Bio, Inc. · Warrant (right to buy)C Conversion	Director	CConversion	+1,665 sh	—	—	1,665
2019-11-08	TELATELA Bio, Inc.P Purchase	Director	PPurchase	+10.2K sh	$13.00	+$133K	12,675
2019-11-08	TELATELA Bio, Inc.P Purchase	Director	PPurchase	+75.9K sh	$13.00	+$987K	260,808

Recent filings

Accepted (ET)
Jan 234
Zuga Matt0001628280-26-003347
SEC(opens sec.gov)
Jan 214
Zuga Matt0001628280-26-002961
SEC(opens sec.gov)
Jan 124
Zuga Matt0001628280-26-001898
SEC(opens sec.gov)
Jan 74
Zuga Matt0001628280-26-001265
SEC(opens sec.gov)
Jun 24
Zuga Matt0001415889-25-015202
SEC(opens sec.gov)
Jan 234
Zuga Matt0001576885-25-000037
SEC(opens sec.gov)
Jan 74
Zuga Matt0001576885-25-000011
SEC(opens sec.gov)
Jun 104
Zuga Matt0001415889-24-016249
SEC(opens sec.gov)
Jan 194
Zuga Matt0001576885-24-000026
SEC(opens sec.gov)
Jan 44
Zuga Matt0001576885-24-000010
SEC(opens sec.gov)
Jan 184
Zuga Matt0001209191-23-003750
SEC(opens sec.gov)

Companies

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465